Fonte: Breast Cancer Research and Treatment. Unidade: FMRP
Assuntos: HORMÔNIO ANTIMÜLLERIANO, NEOPLASIAS MAMÁRIAS, FARMACOTERAPIA, FERTILIDADE, OVÁRIO
A citação é gerada automaticamente e pode não estar totalmente de acordo com as normas
ABNT
GOLDFARB, Shari B et al. Impact of adjuvant chemotherapy or tamoxifen-alone on the ovarian reserve of young women with breast cancer. Breast Cancer Research and Treatment, v. 185, n. 1, p. 165-173, 2021Tradução . . Disponível em: https://doi.org/10.1007/s10549-020-05933-7. Acesso em: 04 dez. 2025.APA
Goldfarb, S. B., Turan, V., Bedoschi, G., Taylan, E., Abdo, N., Cigler, T., et al. (2021). Impact of adjuvant chemotherapy or tamoxifen-alone on the ovarian reserve of young women with breast cancer. Breast Cancer Research and Treatment, 185( 1), 165-173. doi:10.1007/s10549-020-05933-7NLM
Goldfarb SB, Turan V, Bedoschi G, Taylan E, Abdo N, Cigler T, Bang H, Patil S, Dickler MN, Oktay KH. Impact of adjuvant chemotherapy or tamoxifen-alone on the ovarian reserve of young women with breast cancer [Internet]. Breast Cancer Research and Treatment. 2021 ; 185( 1): 165-173.[citado 2025 dez. 04 ] Available from: https://doi.org/10.1007/s10549-020-05933-7Vancouver
Goldfarb SB, Turan V, Bedoschi G, Taylan E, Abdo N, Cigler T, Bang H, Patil S, Dickler MN, Oktay KH. Impact of adjuvant chemotherapy or tamoxifen-alone on the ovarian reserve of young women with breast cancer [Internet]. Breast Cancer Research and Treatment. 2021 ; 185( 1): 165-173.[citado 2025 dez. 04 ] Available from: https://doi.org/10.1007/s10549-020-05933-7
